By Charumini de Silva
Ceylon Finance Today: Despite the challenging factors in the market, Sunshine Healthcare Lanka Ltd., is optimistic of achieving a 15%-20% growth by the end of the year, a senior official said.
Sunshine Healthcare Lanka Ltd., Managing Director Shyam Sathasivam told Ceylon FT that it would be positive for the business if the firm can grow at about 15% -20% despite the challenging environment; hence pushing for 15% -20% was quite possible.
"In 2015, we would be concentrating more on investing in our current product portfolio and driving volumes, while making the product available all over the country. We find that wellness is a growing market, where people chose to buy products that help them to be healthier. Therefore, in that space we have launched a few products and we will continue to invest in that sector as we look for products in that space. The wellness market overall will grow significantly, because it is marketed to the consumer and would take a different approach.
The key areas that we intend to invest more are, non-communicable diseases (NCD), which includes products for cardiovascular, diabetes, chronic kidney failure, and products on pain management, dermatology, nutraceutical and so forth," he added.
Commenting on the new drug policy, Sathasivam said there was lack of clarity in terms of the new drug regulations, and since, pharmaceuticals were a regulated market across the world as it added value to the economy. The question according to Sathasivam was how it was being regulated, what could be learnt from across the world, and what the outcome would be. He stressed that in regulating business, clarity was vital, and that the key stakeholders were engaging with the authorities towards this end.
"The sooner the authorities are going to figure out where the new regulations would take the industry, the better for the stakeholders," he noted.
www.ceylontoday.lk
Ceylon Finance Today: Despite the challenging factors in the market, Sunshine Healthcare Lanka Ltd., is optimistic of achieving a 15%-20% growth by the end of the year, a senior official said.
Sunshine Healthcare Lanka Ltd., Managing Director Shyam Sathasivam told Ceylon FT that it would be positive for the business if the firm can grow at about 15% -20% despite the challenging environment; hence pushing for 15% -20% was quite possible.
"In 2015, we would be concentrating more on investing in our current product portfolio and driving volumes, while making the product available all over the country. We find that wellness is a growing market, where people chose to buy products that help them to be healthier. Therefore, in that space we have launched a few products and we will continue to invest in that sector as we look for products in that space. The wellness market overall will grow significantly, because it is marketed to the consumer and would take a different approach.
The key areas that we intend to invest more are, non-communicable diseases (NCD), which includes products for cardiovascular, diabetes, chronic kidney failure, and products on pain management, dermatology, nutraceutical and so forth," he added.
Commenting on the new drug policy, Sathasivam said there was lack of clarity in terms of the new drug regulations, and since, pharmaceuticals were a regulated market across the world as it added value to the economy. The question according to Sathasivam was how it was being regulated, what could be learnt from across the world, and what the outcome would be. He stressed that in regulating business, clarity was vital, and that the key stakeholders were engaging with the authorities towards this end.
"The sooner the authorities are going to figure out where the new regulations would take the industry, the better for the stakeholders," he noted.
www.ceylontoday.lk
No comments:
Post a Comment